MARLISSA (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the MARLISSA drug offered from Glenmark Pharmaceuticals Inc., USA. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
NON-PROPRIETARY NAME: | Levonorgestrel and Ethinyl Estradiol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-02-29 |
END MARKETING DATE: | 0000-00-00 |
MARLISSA HUMAN PRESCRIPTION DRUG Details:
Item Description | MARLISSA from Glenmark Pharmaceuticals Inc., USA |
LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2012-02-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68462-388_9517cfb6-4022-4e74-a41e-eb73c6480dc6 |
PRODUCT NDC: | 68462-388 |
APPLICATION NUMBER: | ANDA091452 |